HPV DNA and Bladder Cancer Survival
Author Information
Author(s): A Lopez-Beltran, AL Escudero, L Vicioso, E Muñoz, J Carlos Carrasco
Primary Institution: Reina Sofia University Hospital, Cordoba University Medical School
Hypothesis
Does the presence of human papillomavirus (HPV) DNA in transitional cell carcinoma (TCC) specimens correlate with patient survival?
Conclusion
The presence of HPV 16 DNA is associated with reduced survival in bladder cancer patients, but pathological grade remains the only independent prognostic factor.
Supporting Evidence
- 7 out of 76 cases were reactive for HPV 16 DNA.
- Pathological grade was the only independent factor in bladder cancer survival.
- 16 out of 76 cases had koilocytosis, which was significant for survival.
Takeaway
This study found that some bladder cancer patients have a virus called HPV, which can make their cancer worse. Knowing if someone has this virus can help doctors understand how serious their cancer might be.
Methodology
The study analyzed 76 TCC specimens for HPV DNA using PCR and correlated findings with patient survival, considering other clinical variables.
Limitations
The study was limited to a specific population and may not generalize to all bladder cancer patients.
Participant Demographics
Mean age was 66.57 years, with 14 female participants.
Statistical Information
P-Value
P = 0.0418
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website